Mauser-Bunschoten EP - Search Results

1

Factor VIII inhibitor in a patient with mild haemophilia A and an Asn618-->Ser mutation responsive to immune tolerance induction and cyclophosphamide.

Vlot AJ, Wittebol S, Strengers PF, Turenhout EA, Voorberg J, van den Berg HM, Mauser-Bunschoten EP. Vlot AJ, et al. Br J Haematol. 2002 Apr;117(1):136-40. doi: 10.1046/j.1365-2141.2002.03383.x. Br J Haematol. 2002. PMID: 11918545 Free article.

2

Age at first treatment and immune tolerance to factor VIII in severe hemophilia.

van der Bom JG, Mauser-Bunschoten EP, Fischer K, van den Berg HM. van der Bom JG, et al. Thromb Haemost. 2003 Mar;89(3):475-9. Thromb Haemost. 2003. PMID: 12624630

3

Factor VIII half-life and clinical phenotype of severe hemophilia A.

van Dijk K, van der Bom JG, Lenting PJ, de Groot PG, Mauser-Bunschoten EP, Roosendaal G, Grobbee DE, van den Berg HM. van Dijk K, et al. Haematologica. 2005 Apr;90(4):494-8. Haematologica. 2005. PMID: 15820945

4

Successful treatment of severe bleeding in hemophilic target joints by selective angiographic embolization.

Mauser-Bunschoten EP, Zijl JA, Mali W, van Rinsum AC, van den Berg HM, Roosendaal G. Mauser-Bunschoten EP, et al. Blood. 2005 Apr 1;105(7):2654-7. doi: 10.1182/blood-2004-06-2063. Epub 2004 Dec 21. Blood. 2005. PMID: 15613551 Free article.

5

Progression to AIDS in relation to clinical factors and clotting product consumption. A 14-year follow-up of a cohort of 52 Dutch HIV-1-infected haemophilic patients.

Roosendaal G, van der Schouw Y, Mauser-Bunschoten E, Borleffs J, van den Berg H. Roosendaal G, et al. Vox Sang. 1998;75(4):261-6. Vox Sang. 1998. PMID: 9873260 Clinical Trial.

6

Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age-related increase of VWF in von Willebrand disease.

Atiq F, Meijer K, Eikenboom J, Fijnvandraat K, Mauser-Bunschoten EP, van Galen KPM, Nijziel MR, Ypma PF, de Meris J, Laros-van Gorkom BAP, van der Bom JG, de Maat MP, Cnossen MH, Leebeek FWG; WiN study group. Atiq F, et al. Br J Haematol. 2018 Jul;182(1):93-105. doi: 10.1111/bjh.15277. Epub 2018 May 16. Br J Haematol. 2018. PMID: 29767844 Free PMC article.

7

History of non-fatal cardiovascular disease in a cohort of Dutch and British patients with haemophilia.

Fransen van de Putte DE, Fischer K, Makris M, Tait RC, Chowdary P, Collins PW, Meijer K, Roosendaal G, Schutgens RE, Mauser-Bunschoten EP. Fransen van de Putte DE, et al. Eur J Haematol. 2012 Oct;89(4):336-9. doi: 10.1111/j.1600-0609.2012.01835.x. Epub 2012 Aug 3. Eur J Haematol. 2012. PMID: 22775476

8

Bleeding in carriers of hemophilia.

Plug I, Mauser-Bunschoten EP, Bröcker-Vriends AH, van Amstel HK, van der Bom JG, van Diemen-Homan JE, Willemse J, Rosendaal FR. Plug I, et al. Blood. 2006 Jul 1;108(1):52-6. doi: 10.1182/blood-2005-09-3879. Epub 2006 Mar 21. Blood. 2006. PMID: 16551972 Free article.

9

The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia.

Fischer K, van der Bom JG, Mauser-Bunschoten EP, Roosendaal G, Prejs R, de Kleijn P, Grobbee DE, van den Berg M. Fischer K, et al. Blood. 2002 Apr 1;99(7):2337-41. doi: 10.1182/blood.v99.7.2337. Blood. 2002. PMID: 11895765 Free article.

10

Hepatitis C and health-related quality of life among patients with hemophilia.

Posthouwer D, Plug I, van der Bom JG, Fischer K, Rosendaal FR, Mauser-Bunschoten EP. Posthouwer D, et al. Haematologica. 2005 Jun;90(6):846-50. Haematologica. 2005. PMID: 15951299

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

172 results

Search Page